The Diabetes Technology Society Green Diabetes Initiative

Klonoff, David C.; Heinemann, Lutz; Cook, Curtiss B.; Thompson, Bithika; Kerr, David; Han, Julia; Krisiunas, Edward

doi:10.1177/1932296820904175

Cited by 20 publications

(33 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is then the user's responsibility to seal and mail back the sharps disposal container to the sharps manufacturer where it will undergo a safe and standardized disposal process. There are two main options regarding customer sharps return, including (1)…”

Section: The Cpsc-sponsored Sb 212 Billmentioning

confidence: 99%

“…Diabetes Technology Society (DTS) launched the first ever Green Diabetes Initiative in 2020. 1 The Green Diabetes Summit (GDS) was the culmination of a two-year planning process to assemble representatives from the patient community, clinicians, government officials, waste handling service providers, and industry representatives to discuss what can be done to improve sustainability and waste management associated with the use of medical products by people with diabetes (PwD) for their therapy. The number of PwD is increasing and the types of wearable devices and wireless sensors for diabetes therapy are also increasing.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Green Diabetes Summit 2021

Nguyen

Zhang

et al. 2021

J Diabetes Sci Technol

Self Cite

View full text Add to dashboard Cite

On July 21, 2021, Diabetes Technology Society convened the virtual Green Diabetes Summit. The event consisted of 23 representatives from key stakeholder groups based in both the United States and Europe. The purposes of the summit were to (1) provide background on the complexity of addressing sustainability-related issues, including waste management, of diabetes devices from many different perspectives along the products’ life cycle stages, and (2) determine the feasibility and role of a coalition of stakeholders to find solutions, particularly in the design, use, and proper disposal of diabetes devices used in home care that no one stakeholder can resolve on their own.

show abstract

Section: The Cpsc-sponsored Sb 212 Billmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Green Diabetes Summit 2021

Nguyen

Zhang

et al. 2021

J Diabetes Sci Technol

Self Cite

View full text Add to dashboard Cite

show abstract

“…Usually those parts are disposable and attribute to a substantial increase in plastic waste and potentially hazardous medical waste containing sharps, which is an increasing problem worldwide and is fuelled by the, per se favourable, rising availability of CGM. This problem is already acknowledged by the scientific community and is subject to ongoing discussion [15,22]. Therefore, needle-free systems with reusable components can help furthering sustainable diabetes technology and may be a stimulus for other positive developments in this sector including biodegradable solutions or else.…”

Section: Discussionmentioning

confidence: 99%

“…As CGM technology is made available to more and more PLWD the negative impact on environment and natural resources increases due to use of disposable products and accumulating plastic and hazardous medical waste, including hazardous parts like inser-tion needles. Therefore, the Diabetes Technology Society started its Green Diabetes Initiative to positively influence the development of medical devices in terms of sustainability and to reduce the environmental burden of advancement in diabetes technology [15].…”

Section: Introductionmentioning

confidence: 99%

Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study

Hochfellner¹,

Simic²,

Taucher³

et al. 2021

Preprint

View full text Add to dashboard Cite

Aim of this study was to evaluate the accuracy and usability of a novel continuous glucose moni-toring (CGM) system designed for needle-free insertion and reduced environmental impact. We assessed sensor performance of two GlucoMen® Day CGM systems worn simultaneously in eight participants with type 1 diabetes. Self-monitoring of blood glucose (SMBG) was performed reg-ularly over 14 days at home. Participants underwent two standardized 5-hour meal challenges with frequent plasma glucose (PG) measurements using a laboratory reference instrument at the research center. When comparing CGM to PG the overall mean absolute relative difference (MARD) was 9.7 [2.6-14.6]%. The overall MARD of CGM vs SMBG was 13.1 [3.5-18.6]%. In the consensus error grid (CEG) analysis, 98% of both CGM/PG and CGM/SMBG pairs were in the clinically acceptable zones A and B. The analysis confirms that GlucoMen® Day CGM meets the clinical requirements for state-of-the-art CGM. The needle-free insertion technology is well toler-ated by users and reduces medical waste compared to conventional CGM systems.

show abstract

“…To our understanding, the number of patients complaining about the amount of waste generated when using diabetes technology products has increased drastically in the last years, probably to a different level depending on the sensitivity about this topic in a given country/region. 9,10 There is currently no forum at which patients can raise/express such concerns. However, we expect that increasing numbers of patients will be switching to more sustainable products (eg, continuous glucose monitoring systems, blood glucose monitoring system, insulin pumps, automated insulin delivery systems, or insulin pens) if the performance of competing products is perceived to be somewhat comparable but the amount of waste generated differs.…”

Section: The Effect Of Sustainability On Product Developmentmentioning

confidence: 99%